by Marina Temkin | Sep 23, 2026 | Business Enhancements, Startups
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
by Marina Temkin | Sep 22, 2026 | Business Enhancements, Startups
The seven-year-old startup has raised a $350 million Series E to fuel its data-as-a-service approach.